Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 9.02 -1.31% -0.12
EIGR closed down 1.31 percent on Tuesday, December 1, 2020, on 80 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical EIGR trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -1.31%
Inside Day Range Contraction -1.31%
Oversold Stochastic Weakness -1.31%
MACD Bearish Centerline Cross Bearish -1.96%
Oversold Stochastic Weakness -1.96%
Stochastic Reached Oversold Weakness 3.09%
Down 3 Days in a Row Weakness 3.09%
Older End-of-Day Signals for EIGR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 16 hours ago
Down 2 % about 16 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Rose Above Previous Day's High about 18 hours ago
50 DMA Resistance about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Pulmonary Hypertension Orphan Diseases Hypoglycemia Lymphedema

Is EIGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.82
52 Week Low 4.55
Average Volume 573,706
200-Day Moving Average 9.63
50-Day Moving Average 9.33
20-Day Moving Average 9.78
10-Day Moving Average 9.63
Average True Range 0.73
ADX 19.35
+DI 14.73
-DI 18.19
Chandelier Exit (Long, 3 ATRs ) 8.94
Chandelier Exit (Short, 3 ATRs ) 10.80
Upper Bollinger Band 11.11
Lower Bollinger Band 8.46
Percent B (%b) 0.21
BandWidth 27.06
MACD Line -0.11
MACD Signal Line 0.05
MACD Histogram -0.1579
Fundamentals Value
Market Cap 293.44 Million
Num Shares 32.5 Million
EPS -3.65
Price-to-Earnings (P/E) Ratio -2.47
Price-to-Sales 0.00
Price-to-Book 3.34
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.06
Resistance 3 (R3) 10.13 9.86 9.88
Resistance 2 (R2) 9.86 9.60 9.82 9.82
Resistance 1 (R1) 9.44 9.43 9.31 9.37 9.77
Pivot Point 9.17 9.17 9.10 9.13 9.17
Support 1 (S1) 8.75 8.91 8.62 8.68 8.27
Support 2 (S2) 8.48 8.74 8.44 8.22
Support 3 (S3) 8.06 8.48 8.16
Support 4 (S4) 7.99